Takayasu, K., Muguruma, K. and Kinoshita, H. 2022. Durable complete response to combination nivolumab and ipilimumab in metastatic renal cell carcinoma. Trends in Immunotherapy. 6, 1 (Jan. 2022). DOI:https://doi.org/10.24294/ti.v6.i1.1387.